Inventor · disambiguated record
Paul Mollard
Also filed as: MOLLAR PAUL · MOLLARD PAUL
39 granted patents·5 pending applications·360 citations·filing 1974–2023
98Inventor score
Files withPTC THERAPEUTICS INC14BIOELECTRON TECH CORP6UGINE KUHLMANN6EDISON PHARMACEUTICALS INC4CENTRE NAT RECH SCIENT3
Top patents by PatentIndex Score
44 records- 0198US7968746B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesEDISON PHARMACEUTICALS INC·Filed 2008·Granted Jun 28, 2011·46 cites·14 claims
- 0296US8519001B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesJANKOWSKI ORION D·Filed 2011·Granted Aug 27, 2013·30 cites·20 claims
- 0395US9169196B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesEDISON PHARMACEUTICALS INC·Filed 2013·Granted Oct 27, 2015·11 cites·24 claims
- 0495US8716527B22-substituted-p-quinone derivatives for treatment of oxidative stress diseasesHINMAN ANDREW W·Filed 2009·Granted May 6, 2014·35 cites·14 claims
- 0593US11304914B2Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamidePTC THERAPEUTICS INC·Filed 2020·Granted Apr 19, 2022·2 cites·26 claims
- 0692US11174212B22,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disordersPTC THERAPEUTICS INC·Filed 2021·Granted Nov 16, 2021·5 cites·32 claims
- 0791US11186559B2Methods for enriching alpha-tocotrienol from mixed tocol compositionsPTC THERAPEUTICS INC·Filed 2020·Granted Nov 30, 2021·3 cites·23 claims
- 0891US9278085B2Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkersMILLER GUY M·Filed 2007·Granted Mar 8, 2016·19 cites·14 claims
- 0991US9162957B2Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienolsMOLLARD PAUL·Filed 2012·Granted Oct 20, 2015·19 cites·13 claims
- 1088US11667596B22,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disordersPTC THERAPEUTICS INC·Filed 2021·Granted Jun 6, 2023·1 cites·19 claims
- 1188US10751302B2Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamidePTC THERAPEUTICS INC·Filed 2019·Granted Aug 25, 2020·2 cites·20 claims
- 1286US6852895B2Practical, cost-effective synthesis of CoQ10ZYMES INC·Filed 2002·Granted Feb 8, 2005·18 cites·14 claims
- 1382US10251847B2Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamideBIOELECTRON TECH CORP·Filed 2015·Granted Apr 9, 2019·3 cites·21 claims
- 1482US4044103AStorage-stable sodium chloriteUGINE KUHLMANN·Filed 1974·Granted Aug 23, 1977·24 cites·13 claims
- 1582US2023364029A1Polymorphic forms of (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamidePTC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1681US10745371B2Methods for enriching alpha-tocotrienol from mixed tocol compositionsPTC THERAPEUTICS INC·Filed 2016·Granted Aug 18, 2020·2 cites·21 claims
- 1781US9932286B2Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkersBIOELECTRON TECH CORP·Filed 2015·Granted Apr 3, 2018·3 cites·8 claims
- 1879US11840497B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesPTC THERAPEUTICS INC·Filed 2021·Granted Dec 12, 2023·0 cites·13 claims
- 1978US11938101B2Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamidePTC THERAPEUTICS INC·Filed 2022·Granted Mar 26, 2024·0 cites·13 claims
- 2075US2023339835A12,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disordersPTC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2174US11746077B22,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disordersPTC THERAPEUTICS INC·Filed 2022·Granted Sep 5, 2023·0 cites·29 claims
- 2271US10968166B24-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesPTC THERAPEUTICS INC·Filed 2018·Granted Apr 6, 2021·0 cites·9 claims
- 2370US11560364B2Methods for enriching alpha-tocotrienol from mixed tocol compositionsPTC THERAPEUTICS INC·Filed 2021·Granted Jan 24, 2023·0 cites·26 claims
- 2468US4004988AMethod of preparing sodium chlorate by electrolysisUGINE KUHLMANN·Filed 1974·Granted Jan 25, 1977·13 cites·1 claims
- 2567US10167251B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesBIOELECTRON TECH CORP·Filed 2016·Granted Jan 1, 2019·0 cites·33 claims
- 2667US5580396ATreatment of pulverant magnetic materials and products thus obtainedCENTRE NAT RECH SCIENT·Filed 1994·Granted Dec 3, 1996·23 cites·9 claims
- 2766US9546132B24-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseasesEDISON PHARMACEUTICALS INC·Filed 2015·Granted Jan 17, 2017·0 cites·12 claims
- 2866US4211759AHigh-density sodium perborate and method of preparationUGINE KUHLMANN·Filed 1979·Granted Jul 8, 1980·12 cites·18 claims
- 2964US10202325B2Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienolsBIOELECTRON TECH CORP·Filed 2018·Granted Feb 12, 2019·0 cites·20 claims
- 3063US4803291AParticulate compositions of ferromagnetic metal oxalates in the form of submicronic acicular particles, the preparation of same and application thereofCENTRE NAT RECH SCIENT·Filed 1986·Granted Feb 7, 1989·16 cites·19 claims
- 3162US4022874AProcess for the production of sodium percarbonateUGINE KUHLMANN·Filed 1974·Granted May 10, 1977·10 cites·5 claims
- 3262US3994819AMethod for the preparation of acicular particles containing iron and other divalent metalsANVAR·Filed 1975·Granted Nov 30, 1976·10 cites·14 claims
- 3361US10029971B2Methods for selective oxidation of alpha tocotrienol in the presence of non-alpha tocotrienolsBIOELECTRON TECH CORP·Filed 2017·Granted Jul 24, 2018·0 cites·13 claims
- 3461US4971734AMethod of making nuclear fuel pellets, comprising producing and using pourable, frittable powders obtained directly by precipitation of peroxidesPECHINEY URANIUM·Filed 1989·Granted Nov 20, 1990·12 cites·22 claims
- 3559US4018874AProcess for the production of sodium percarbonate by atomizationUGINE KUHLMANN·Filed 1974·Granted Apr 19, 1977·9 cites·10 claims
- 3659US2024336586A1Methods for synthesis of racemic, scalemic, and chiral alpha-tocotrienol quinonePTC THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3757US9567279B2Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienolsEDISON PHARMACEUTICALS INC·Filed 2015·Granted Feb 14, 2017·0 cites·14 claims
- 3854US4808327ACompositions of particulate magnetic oxides with a defect spinel structure, preparation thereof and application thereofCENTRE NAT RECH SCIENT·Filed 1986·Granted Feb 28, 1989·10 cites·16 claims
- 3951US5232617AProcess for the preparation of hexaferritesRECH SCIENTIIQUE CENTRE NAT DE·Filed 1991·Granted Aug 3, 1993·11 cites·22 claims
- 4047US4190635AProcesses for preparing sodium percarbonateUGINE KUHLMANN·Filed 1978·Granted Feb 26, 1980·6 cites·5 claims
- 4147US2005137410A1Practical, cost-effective synthesis of CoQ10ZYMES INC·Filed 2004·Application pending·0 cites
- 4237US9464016B2Catechol derivatives for treatment of oxidative stress diseasesMOLLARD PAUL·Filed 2012·Granted Oct 11, 2016·0 cites·10 claims
- 4337US4096080ASolid solutions of magnetic oxides and method of preparationANVAR·Filed 1975·Granted Jun 20, 1978·5 cites·12 claims
- 4432US2018002247A1Methods for chiral resolution of troloxBIOELECTRON TECH CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Mollard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →